☆ 4.8 Article

Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases

FRONTIERS IN IMMUNOLOGY (2021)

Related references

Note: Only part of the references are listed.

Article Infectious Diseases

A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization

David Peterhoff et al.

Summary: The study developed a specific and sensitive enzyme linked immunosorbent assay (ELISA) for detection of anti-SARS-CoV-2 antibody levels. The ELISA showed high specificity and strong correlation in detecting SARS-CoV-2 antibodies, and was able to generate robust antibody levels 10 days after symptom onset.

INFECTION (2021)

Add to Collection

Article Biochemistry & Molecular Biology

COVID-19-neutralizing antibodies predict disease severity and survival

Wilfredo F. Garcia-Beltran et al.

Summary: Severe cases of COVID-19 show increased inflammatory markers, lymphopenia, pro-inflammatory cytokines, and high antibody levels. High neutralization potency is a predictor of survival. Patient sera can neutralize different strains, indicating cross-protection from reinfection.

CELL (2021)

Add to Collection

Article Immunology

A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity

Vincent Legros et al.

Summary: The study investigated the neutralizing antibody response in serum samples from 140 confirmed SARS-CoV-2 infections, finding that antibody titers correlated with disease severity and anti-spike IgG levels. Post-recovery, patients' nAb activity declined more rapidly compared to individuals infected with other coronaviruses, and previous infection by human coronaviruses did not generate protective nAbs against SARS-CoV-2. Additionally, the D614G mutation in the spike protein did not lead to neutralization escape.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity

Sarah L. Caddy et al.

Summary: The study revealed a new mechanism of immune protection mediated by anti-N antibodies through cytosolic Fc receptor and TRIM21. These antibodies target N for degradation and generate CTLs, facilitating efficient viral clearance. This highlights the importance of N as a vaccine target and the synergy between antibodies and T cells in immunity.

EMBO JOURNAL (2021)

Add to Collection

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

Add to Collection

Article Cell Biology

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin et al.

Summary: The study found that humoral immune responses to SARS-CoV-2 infection are dominated by IgA antibodies, with specific IgA plasmablasts rapidly expanding shortly after symptom onset and peaking in the third week of the disease. Virus-specific antibody responses include IgG, IgM, and IgA, with IgA playing a greater role in virus neutralization compared to IgG.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Review Virology

Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval

Ebenezer Tumban

Summary: SARS-CoV-2 candidate vaccines targeting the spike protein are showing promising results in phase I/II trials, with some already granted emergency use authorization. Expectations are high for phase III trials and recommendations for post-approval phase IV studies.

VIRUSES-BASEL (2021)

Add to Collection

Article Multidisciplinary Sciences

Neutralizing antibody titres in SARS-CoV-2 infections

Eric H. Y. Lau et al.

Summary: In this study, researchers quantified SARS-CoV-2 specific neutralizing antibodies using plaque reduction neutralization (PRNT) assays on 195 patients in different disease states. They found that patients with severe disease had higher peaks of neutralizing antibody titres than patients with mild or asymptomatic infections, and that serum neutralizing antibody persists for over 6 months in most people.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness

Chandima Jeewandara et al.

Summary: This study found that the levels of NAbs in COVID-19 patients were associated with disease severity and duration of viral shedding. Lower levels of NAbs were seen in patients with mild illness, and these antibodies may decline during the recovery period.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Microbiology

Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion

Guido Papa et al.

Summary: Research suggests that furin plays a promoting role in SARS-CoV-2 infectivity and cell-cell spread, but it is not essential, indicating that furin inhibitors may reduce but not completely prevent viral spread.

PLOS PATHOGENS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection

Elizabeth M. Anderson et al.

Summary: Our research indicates that most individuals had antibodies against other seasonal human coronaviruses before the COVID-19 pandemic. Around 20% of these individuals also had antibodies that cross-reacted with SARS-CoV-2, but these antibodies did not offer protection against SARS-CoV-2 infections or hospitalizations.

CELL (2021)

Add to Collection

Article Allergy

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19

Carlo Cervia et al.

Summary: The study found that severe COVID-19 patients experienced a significant increase in SARS-CoV-2 antibody titers after symptom onset, especially with high IgA titers, while mild cases may exhibit transient production of SARS-CoV-2-specific antibodies. Interestingly, some healthcare workers with negative serum antibody titers showed SARS-CoV-2-specific IgA in mucosal fluids with virus-neutralizing capacity in some cases.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Biochemical Research Methods

Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples

Livia Mazzini et al.

Summary: This study aimed to detect SARS-CoV-2-specific antibodies in human serum samples to predict population immunity, identify potential infectious individuals, and confirm the significant neutralizing effect of antibodies against the receptor-binding domain of the virus spike protein.

JOURNAL OF IMMUNOLOGICAL METHODS (2021)

Add to Collection

Letter Medicine, General & Internal

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

Charlotte Manisty et al.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity

Benjamin Trinite et al.

Summary: The levels of neutralizing antibodies significantly increase with disease severity in COVID-19 patients. Hospitalized individuals have higher titers compared to those with mild symptoms or asymptomatic, with no significant impact from age, gender, or treatment on the neutralizing titers.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Medicine, General & Internal

Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS-CoV-2 infection

Charlotte Manisty et al.

Summary: This study found that post-SARS-CoV-2 infection, there are heterogeneous immune responses, with anti-S1 antibodies being cleared faster, transitioning more quickly to low levels of production, and experiencing greater reductions in production rate. In mild infections, relying solely on anti-S1 serology may underestimate the incidence of infections.

EBIOMEDICINE (2021)

Add to Collection

Review Microbiology

Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization

Yongjun Sui et al.

Summary: Robust immune responses are crucial in combating COVID-19, with high levels of antibodies and Th1 responses being able to prevent viral transmission and disease progression. In addition to genetic and innate immune factors, trained immunity and local mucosal immunity also play a role in reducing infection risk and mitigating disease severity.

PATHOGENS (2021)

Add to Collection

Review Immunology

A comparative review of immunoassays for COVID-19 detection

Elham Mohit et al.

Summary: Serology testing has been considered as a valuable tool in diagnosing COVID-19, especially for RT-PCR negative individuals. Different serological methods, such as ELISAs, CLIAs, and LFIAs, were compared for their diagnostic performance. Results showed that higher sensitivity could be achieved by determining combined IgG/IgM titers and targeting spike (S) antigen for neutralization antibody detection. Additionally, ELISA/CLIA-based methods were found to have higher sensitivity compared to LFIA devices.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Correlates of protection from SARS-CoV-2 infection

Florian Krammer

LANCET (2021)

Add to Collection

Letter Medicine, General & Internal

WHO International Standard for anti-SARS-CoV-2 immunoglobulin

Paul A. Kristiansen et al.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Victoria Jane Hall et al.

Summary: This study investigated whether antibodies against SARS-CoV-2 were associated with a decreased risk of symptomatic and asymptomatic reinfection. It found that individuals with a previous history of SARS-CoV-2 infection had an 84% lower risk of reinfection, with a median protective effect lasting for 7 months following primary infection.

LANCET (2021)

Add to Collection

Review Virology

Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines

Daniele Focosi et al.

Summary: The Spike protein serves as the target for antibody-based therapeutics and vaccines, but mutations in Spike could impact their efficacy. Monitoring mutations is crucial for adjusting the therapeutics inventory. Different clades exhibit varying mutation combinations, with a focus on the UK, South African, and Brazilian variants.

REVIEWS IN MEDICAL VIROLOGY (2021)

Add to Collection

Article Cell Biology

The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies

James T. Earnest et al.

Summary: This study demonstrates that non-neutralizing antibodies can provide protection against Mayaro virus infection in mice through Fc effector functions, which involve monocytes facilitating the binding, uptake, and clearance of the virus without antibody-dependent enhancement of infection. The findings suggest that humoral protection against alphaviruses may rely on non-neutralizing antibodies contributing through Fc-dependent mechanisms that accelerate viral clearance.

CELL REPORTS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

A functional assay for serum detection of antibodies against SARS-CoV-2 nucleoprotein

Anna Albecka et al.

Summary: The humoral immune response to SARS-CoV-2 results in antibodies against spike (S) and nucleoprotein (N). A new in vitro method called EDNA has been developed to quantitatively measure N-antibody activity in unpurified serum from SARS-CoV-2 convalescents. The study found that N antibodies can neutralize SARS-CoV-2 intracellularly and cell-autonomously, but require the cytosolic Fc receptor TRIM21.

EMBO JOURNAL (2021)

Add to Collection

Review Biochemical Research Methods

SARS-CoV-2 serology testing: Progress and challenges

Aria C. Shi et al.

Summary: The COVID-19 pandemic has had a devastating impact on society and economy, with the development of an effective vaccine and establishment of herd immunity being key to ending the pandemic. Reliable serology testing is crucial for diagnosing infections and monitoring neutralizing antibody levels, but there are still challenges in the development and application of these tests.

JOURNAL OF IMMUNOLOGICAL METHODS (2021)

Add to Collection

Article Medicine, General & Internal

Diagnostic Accuracy of Electro-Chemiluminescence Immunoassay Anti-SARS-CoV-2 Serological Test

Nayab Afzal et al.

Summary: The study demonstrates that the fully automated electro-chemiluminescence immunoassay (ECLIA) anti-SARS-CoV-2 serological test has good diagnostic accuracy in detecting past COVID-19 infections and can be used for screening and seroprevalence surveys.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Add to Collection

Article Immunology

Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort

Alexandra Rockstroh et al.

Summary: Studying the humoral protective immune response post SARS-CoV-2 infections is crucial for assessing reinfection risk, improving diagnostic methods, and evaluating vaccine trials. This research analyzed the dynamics of neutralizing antibodies and IgG responses in COVID-19 patients, identifying potential diagnostic markers for estimating neutralizing protection.

EMERGING MICROBES & INFECTIONS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat et al.

NATURE MEDICINE (2020)

Add to Collection

Review Pathology

Review of Current Advances in Serologic Testing for COVID-19

Andrea P. Espejo et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)

Add to Collection

Article Infectious Diseases

Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients

E. Tuaillon et al.

JOURNAL OF INFECTION (2020)

Add to Collection

Article Biochemistry & Molecular Biology

A thermostable, closed SARS-CoV-2 spike protein trimer

Xiaoli Xiong et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

Add to Collection

Article Microbiology

Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate

Amin Addetia et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

Add to Collection

Article Virology

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays

Inesa Hyseni et al.

VIRUSES-BASEL (2020)

Add to Collection

Article Microbiology

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

Jeffrey Seow et al.

NATURE MICROBIOLOGY (2020)

Add to Collection

Article Medicine, Research & Experimental

Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity

Kathleen M. McAndrews et al.

JCI INSIGHT (2020)

Add to Collection

Review Multidisciplinary Sciences

Antibody response to SARS-CoV-2 infection in humans: A systematic review

Nathan Post et al.

PLOS ONE (2020)

Add to Collection

Article Multidisciplinary Sciences

Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19

Kening Li et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Immunology

Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection

Michael W. Russell et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Review Immunology

Humoral Responses and Serological Assays in SARS-CoV-2 Infections

Yannick Galipeau et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

Katharina Roltgen et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Review Medicine, Research & Experimental

Antibody responses in COVID-19 patients

Shuying Liu et al.

JOURNAL OF BIOMEDICAL RESEARCH (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Non-neutralizing Antibodies Directed at Conservative Influenza Antigens

E. S. Sedova et al.

ACTA NATURAE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

A Method for the Acute and Rapid Degradation of Endogenous Proteins

Dean Clift et al.

CELL (2017)

Add to Collection

Article Multidisciplinary Sciences

Dose-Response Analysis Using R

Christian Ritz et al.

PLOS ONE (2015)

Add to Collection

Article Multidisciplinary Sciences

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

Donna L. Mallery et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Add to Collection

Article Oncology

Altered sirtuin expression is associated with node-positive breast cancer

N. Ashraf et al.

BRITISH JOURNAL OF CANCER (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.